A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261736A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides
12/04/2002	EP1261735A2 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
12/04/2002	EP1261723A2 Hybrid expression of neisserial proteins
12/04/2002	EP1261714A2 Muteins of interleukin-13 (il-13)
12/04/2002	EP1261713A2 Human ion channels
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261711A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma
12/04/2002	EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261700A2 Cis acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region
12/04/2002	EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis
12/04/2002	EP1261640A2 Inflammation-related gene
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261638A2 Human fgf-23 gene and gene expression products
12/04/2002	EP1261637A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261634A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261633A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261632A2 Cryptococcal mannoproteins or equivalents thereof for use in modulating neutrophil migration
12/04/2002	EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses
12/04/2002	EP1261628A2 Novel molecules of the card-related protein family and uses thereof
12/04/2002	EP1261627A2 Antibodies against plasma cells
12/04/2002	EP1261626A1 Bombesin analogs for treatment of cancer
12/04/2002	EP1261625A2 Memno peptides, a process for their preparation and their use
12/04/2002	EP1261624A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme
12/04/2002	EP1261623A1 New retinol derivatives, the method of preparations and the uses thereof
12/04/2002	EP1261622A2 Purified lh
12/04/2002	EP1261618A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261427A2 Microfabricated devices and methods for storage and selective exposure of chemicals
12/04/2002	EP1261380A1 Nucleic acids, proteins and antibodies
12/04/2002	EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261371A1 Membrane estrogen receptor-directed therapy in breast cancer
12/04/2002	EP1261369A2 Compositions and methods for tumor-targeted delivery of effector molecules
12/04/2002	EP1261368A2 Lipase-containing composition and methods of use thereof
12/04/2002	EP1261367A1 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
12/04/2002	EP1261366A1 Adjuvant treatment by in vivo activation of dendritic cells
12/04/2002	EP1261365A1 Product and method for biological anchoring of connective tissue to bone
12/04/2002	EP1261364A1 Method of treating or inhibiting cellular injury or cell death
12/04/2002	EP1261363A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/04/2002	EP1261362A2 Novel amino acid and peptide inhibitors of staphylococcus virulence
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261360A1 Casein derived peptides and uses thereof in therapy
12/04/2002	EP1261353A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
12/04/2002	EP1261325A2 Nitroacridine/tumor inhibitor compositions
12/04/2002	EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application
12/04/2002	EP1261317A2 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
12/04/2002	EP1261314A1 Methods using phytol to improve the appearance of skin and compositions for such methods
12/04/2002	EP1212352A4 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
12/04/2002	EP1030867A4 Mammalian milk growth factor
12/04/2002	EP1028737A4 Human mesenchymal stem cells from peripheral blood
12/04/2002	EP0942972B1 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	EP0869774B1 Method for manufacturing sustained release particles
12/04/2002	EP0858262B1 Thrombin inhibitors
12/04/2002	EP0815124B1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/04/2002	EP0814837B1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
12/04/2002	EP0783324B1 Cellular immunity-inducing conjugate
12/04/2002	EP0772451B1 Treatment of type ii diabetes mellitus with amylin agonists
12/04/2002	EP0752863B1 Use of biopolymers for digestive tract injuries treatment
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	EP0714441B1 Recombinant cladosporium herbarum allergens
12/04/2002	EP0693937B1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0651648B1 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1383375A Treatment of human herpesviruses using hyperthermia
12/04/2002	CN1382801A Polypeptide-DNA topoisomerase 1-9.13 and polynucleotide for coding it
12/04/2002	CN1382800A Polypeptide-chitotriase-52.03 and polynucleotide for coding it
12/04/2002	CN1382799A Polypeptide-human carboxylatase-24.64 and polynucleotide for coding it
12/04/2002	CN1382798A Polypeptide-diphosphoadenosine ribodiphosphatase-38.5 and pharmaceutical compound containing it
12/04/2002	CN1382796A Polypeptide-human inosine triphosphate pyrophosphohydrolase-21.34 and pharmaceutic compound containing it
12/04/2002	CN1382795A Polypeptide-butanone kinase-72.49 and polynucleotide for coding it
12/04/2002	CN1382794A Polypeptide-N-acetylgalactosamine transferase-38.61 and polynucleotide for coding it
12/04/2002	CN1382793A Polypeptide-amino acid N-acyltransferase-12.38 and polynucleotide for coding it
12/04/2002	CN1382792A Polypeptide-DNA methylase-9.35 and polynucleotide for coding it
12/04/2002	CN1382791A Polypeptide-histidinol dehydrogenase-9.02 and polynucleotide for coding it
12/04/2002	CN1382790A Polypeptide-tryptophan permease-9.13 and polynucleotide for coding it
12/04/2002	CN1382789A Polypeptide-DNA polymerase -8.91 and polynucleotide for coding it
12/04/2002	CN1382697A Human testis development specific protein-28 gene coding protein
12/04/2002	CN1382696A Human testis development specific protein-25 gene coding protein
12/04/2002	CN1382695A Human testis development specific protein-22 gene coding protein
12/04/2002	CN1382694A Human testis development specific protein-17 gene coding protein
12/04/2002	CN1382491A Nutritive SOD capsule
12/04/2002	CN1382490A Treatment application of selectivity PDE10 suppressant
12/04/2002	CN1382489A Application of alpha-receptor kinetin in preparing medicine
12/04/2002	CN1382448A Genetic switch medicine for treating tumor
12/04/2002	CN1382377A Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002	US6489465 Viricides, anticancer or antitumor agents
12/03/2002	US6489463 Thymosin β-15 promoter and uses thereof
12/03/2002	US6489459 Hop=homolog of presenilin; isolated nucleic acid, vector and host cell; related to alzheimer's disease
12/03/2002	US6489453 Chandra: a TH1-specific gene
12/03/2002	US6489451 Enzyme hydrolyzes fibrin, dissolves blood clots, and prevents platelet aggregation
12/03/2002	US6489449 Viricides
12/03/2002	US6489448 Antibody to a protein with thiol specific antioxidant (tsa) activity; vaccines
12/03/2002	US6489447 Protein purification

1 ... 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 ... 3163